These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

859 related items for PubMed ID: 12448000

  • 41. Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpresses vascular endothelial growth factor.
    Balbay MD, Pettaway CA, Kuniyasu H, Inoue K, Ramirez E, Li E, Fidler IJ, Dinney CP.
    Clin Cancer Res; 1999 Apr; 5(4):783-9. PubMed ID: 10213213
    [Abstract] [Full Text] [Related]

  • 42. Skeletal muscle capillarity and angiogenic mRNA levels after exercise training in normoxia and chronic hypoxia.
    Olfert IM, Breen EC, Mathieu-Costello O, Wagner PD.
    J Appl Physiol (1985); 2001 Sep; 91(3):1176-84. PubMed ID: 11509513
    [Abstract] [Full Text] [Related]

  • 43. Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression.
    Itakura J, Ishiwata T, Friess H, Fujii H, Matsumoto Y, Büchler MW, Korc M.
    Clin Cancer Res; 1997 Aug; 3(8):1309-16. PubMed ID: 9815813
    [Abstract] [Full Text] [Related]

  • 44. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC, Wood J, Mandriota SJ, Schnell C, Ferrari S, Mestan J, Zhu Z, Witte L, Pepper MS.
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
    [Abstract] [Full Text] [Related]

  • 45. Expression of two angiogenic factors, vascular endothelial growth factor and platelet-derived endothelial cell growth factor in human pancreatic cancer, and its relationship to angiogenesis.
    Fujimoto K, Hosotani R, Wada M, Lee JU, Koshiba T, Miyamoto Y, Tsuji S, Nakajima S, Doi R, Imamura M.
    Eur J Cancer; 1998 Aug; 34(9):1439-47. PubMed ID: 9849429
    [Abstract] [Full Text] [Related]

  • 46. Expression of basic fibroblast growth factor, vascular endothelial growth factor, and thrombospondin-1 related to microvessel density in nonaggressive and aggressive basal cell carcinomas.
    Oh CK, Kwon YW, Kim YS, Jang HS, Kwon KS.
    J Dermatol; 2003 Apr; 30(4):306-13. PubMed ID: 12707467
    [Abstract] [Full Text] [Related]

  • 47. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis.
    Freeman MR, Schneck FX, Gagnon ML, Corless C, Soker S, Niknejad K, Peoples GE, Klagsbrun M.
    Cancer Res; 1995 Sep 15; 55(18):4140-5. PubMed ID: 7545086
    [Abstract] [Full Text] [Related]

  • 48. The relevance of cell proliferation, vascular endothelial growth factor, and basic fibroblast growth factor production to angiogenesis and tumorigenicity in human glioma cell lines.
    Ke LD, Shi YX, Im SA, Chen X, Yung WK.
    Clin Cancer Res; 2000 Jun 15; 6(6):2562-72. PubMed ID: 10873113
    [Abstract] [Full Text] [Related]

  • 49. Angiogenic protein expression in advanced epithelial ovarian cancer.
    Barton DP, Cai A, Wendt K, Young M, Gamero A, De Cesare S.
    Clin Cancer Res; 1997 Sep 15; 3(9):1579-86. PubMed ID: 9815846
    [Abstract] [Full Text] [Related]

  • 50. Vascular endothelial growth factor splice variants and their prognostic value in breast and ovarian cancer.
    Stimpfl M, Tong D, Fasching B, Schuster E, Obermair A, Leodolter S, Zeillinger R.
    Clin Cancer Res; 2002 Jul 15; 8(7):2253-9. PubMed ID: 12114428
    [Abstract] [Full Text] [Related]

  • 51. Vascular endothelial growth factor acts as a pericyte mitogen under hypoxic conditions.
    Yamagishi S, Yonekura H, Yamamoto Y, Fujimori H, Sakurai S, Tanaka N, Yamamoto H.
    Lab Invest; 1999 Apr 15; 79(4):501-9. PubMed ID: 10212003
    [Abstract] [Full Text] [Related]

  • 52. Unique properties of 189 amino acid isoform of vascular endothelial growth factor in tumorigenesis.
    Tomii Y, Yamazaki H, Sawa N, Ohnishi Y, Kamochi J, Tokunaga T, Osamura Y, Sadahiro S, Kijima H, Abe Y, Ueyama Y, Tamaoki N, Nakamura M.
    Int J Oncol; 2002 Dec 15; 21(6):1251-7. PubMed ID: 12429975
    [Abstract] [Full Text] [Related]

  • 53. Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function.
    Grunstein J, Roberts WG, Mathieu-Costello O, Hanahan D, Johnson RS.
    Cancer Res; 1999 Apr 01; 59(7):1592-8. PubMed ID: 10197634
    [Abstract] [Full Text] [Related]

  • 54. Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis.
    Lee AH, Dublin EA, Bobrow LG, Poulsom R.
    J Pathol; 1998 Aug 01; 185(4):394-401. PubMed ID: 9828838
    [Abstract] [Full Text] [Related]

  • 55. Modulation of angiogenesis and tumorigenicity of human melanocytic cells by vascular endothelial growth factor and basic fibroblast growth factor.
    Graeven U, Rodeck U, Karpinski S, Jost M, Philippou S, Schmiegel W.
    Cancer Res; 2001 Oct 01; 61(19):7282-90. PubMed ID: 11585767
    [Abstract] [Full Text] [Related]

  • 56. Vascular endothelial growth factor is a potent angiogenic factor in AIDS-associated Kaposi's sarcoma-derived spindle cells.
    Nakamura S, Murakami-Mori K, Rao N, Weich HA, Rajeev B.
    J Immunol; 1997 May 15; 158(10):4992-5001. PubMed ID: 9144519
    [Abstract] [Full Text] [Related]

  • 57. Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus.
    Lord RV, Park JM, Wickramasinghe K, DeMeester SR, Oberg S, Salonga D, Singer J, Peters JH, Danenberg KD, Demeester TR, Danenberg PV.
    J Thorac Cardiovasc Surg; 2003 Feb 15; 125(2):246-53. PubMed ID: 12579092
    [Abstract] [Full Text] [Related]

  • 58. Hypoxia-induced up-regulation of angiogenin in human malignant melanoma.
    Hartmann A, Kunz M, Köstlin S, Gillitzer R, Toksoy A, Bröcker EB, Klein CE.
    Cancer Res; 1999 Apr 01; 59(7):1578-83. PubMed ID: 10197632
    [Abstract] [Full Text] [Related]

  • 59. Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells.
    Zhang HT, Craft P, Scott PA, Ziche M, Weich HA, Harris AL, Bicknell R.
    J Natl Cancer Inst; 1995 Feb 01; 87(3):213-9. PubMed ID: 7535859
    [Abstract] [Full Text] [Related]

  • 60. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F, Robles AI, Duran H, Murillas R, Quintanilla M, Cano A, Conti CJ, Jorcano JL.
    Cancer Res; 1996 Dec 01; 56(23):5391-6. PubMed ID: 8968091
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 43.